These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
50. Rotigotine transdermal system: developing continuous dopaminergic delivery to treat Parkinson's disease and restless legs syndrome. Benitez A; Edens H; Fishman J; Moran K; Asgharnejad M Ann N Y Acad Sci; 2014 Nov; 1329():45-66. PubMed ID: 25145951 [TBL] [Abstract][Full Text] [Related]
51. Overnight switch from oral dopaminergic agonists to transdermal rotigotine patch in subjects with Parkinson disease. LeWitt PA; Boroojerdi B; MacMahon D; Patton J; Jankovic J Clin Neuropharmacol; 2007; 30(5):256-65. PubMed ID: 17909303 [TBL] [Abstract][Full Text] [Related]
52. A controlled trial of rotigotine monotherapy in early Parkinson's disease. Parkinson Study Group Arch Neurol; 2003 Dec; 60(12):1721-8. PubMed ID: 14676046 [TBL] [Abstract][Full Text] [Related]
53. Rotigotine effect on sleep in a de novo Parkinson's Disease patient affected by periodic limb movement disorder. Liguori C; Placidi F; Stefani A; Mercuri NB; Marciani MG; Stanzione P; Pierantozzi M Parkinsonism Relat Disord; 2015 Dec; 21(12):1476-8. PubMed ID: 26578038 [No Abstract] [Full Text] [Related]
54. Rotigotine: transdermal dopamine agonist treatment of Parkinson's disease and restless legs syndrome. Splinter MY Ann Pharmacother; 2007 Feb; 41(2):285-95. PubMed ID: 17213296 [TBL] [Abstract][Full Text] [Related]
58. Switching from an oral dopamine receptor agonist to rotigotine transdermal patch: a review of clinical data with a focus on patient perspective. Chung SJ; Asgharnejad M; Bauer L; Benitez A; Boroojerdi B; Heidbrede T; Little A; Kim HJ Expert Rev Neurother; 2017 Jul; 17(7):737-749. PubMed ID: 28548894 [TBL] [Abstract][Full Text] [Related]
59. Outcomes from switching from rotigotine patch to alternate therapies in Parkinson's disease. Chitnis S; Jaffery M; Dewey RB Int J Neurosci; 2012 Jan; 122(1):22-5. PubMed ID: 21864207 [TBL] [Abstract][Full Text] [Related]
60. Effect of rotigotine on sleep and quality of life in Parkinson's disease patients: post hoc analysis of RECOVER patients who were symptomatic at baseline. Ghys L; Surmann E; Whitesides J; Boroojerdi B Expert Opin Pharmacother; 2011 Sep; 12(13):1985-98. PubMed ID: 21790503 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]